SciSparc (NASDAQ:SPRC) Shares Down 4.1%

SciSparc Ltd. (NASDAQ:SPRC) traded down 4.1% during mid-day trading on Wednesday . The company traded as low as $0.30 and last traded at $0.30. 665,312 shares traded hands during trading, a decline of 61% from the average session volume of 1,719,068 shares. The stock had previously closed at $0.32.

SciSparc Stock Up 4.1 %

The company’s fifty day moving average price is $0.45 and its two-hundred day moving average price is $1.20.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SciSparc stock. Renaissance Technologies LLC purchased a new position in shares of SciSparc Ltd. (NASDAQ:SPRC) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned approximately 5.59% of SciSparc as of its most recent SEC filing. 25.06% of the stock is currently owned by institutional investors.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.